print this page

EU/US COMBINATION PRODUCTS

There are important differences in US and European requirements for drug-device combination products and drug delivery devices. These differences can sometimes represent significant difficulties in reaching project milestones when they are not understood sufficiently early in the project management process.

Donawa Lifescience Consulting (DLC) has the knowledge and experience to assist in the development of effective regulatory, clinical study, and quality system strategies, so that important project milestones can be met.

For further information on how DLC may be able to help bring your combination product to market, click here.